CVM logo

CEL-SCI (CVM)

Profile

Full Name

CEL-SCI Corporation

Ticker Symbol

CVM

Exchange

NYSE American

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

December 8, 1983

Indexes

Not included

Website

http://cel-sci.com

Employees

43

Key Details

Price

$0.31(+47.62%)

Market cap

Last Dividend

$62.50

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$0.51(+30.14% YoY)

PE ratio

-

Next earnings date

May 15, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.31
CVM price is $0.31

30-Day Relative Volume

3.53
CVM 30-day relative volume is 3.53

Price Performance

Price Most recent change

+47.62%
CVM price was up +47.62% on Apr 11, 2025

Price YTD change

-22.5%
CVM price is down -22.5% since January 1st

Price 1-year change

-81.33%
CVM price is down -81.33% year-on-year

Price 3-year change

-91.32%
CVM price is down -91.32% over the past 3 years

Price Range

Price All-time high

$21562.50
CVM price is currently -100.00% below its historical high of $21562.50

Price 3-year low

$0.18
CVM price is currently +72.22% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$23.94M
CVM market capitalization is $23.94 million

Market cap 3-year change

-84.52%
CVM market capitalization is down -84.52% over the past 3 years

Market cap All-time high

$1.12B
CVM market capitalization is currently -97.87% below its historical high of $1.12 billion

Market cap sector rank

29.42%
CVM market capitalization is higher than 29.42% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+42.76%
CVM shares outstanding is up +42.76% year-on-year

Shares Outstanding 3-Year Change

+78.3%
CVM shares outstanding is up +78.3% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.68
CVM beta is 0.68

200-day SMA

$0.76
CVM price is currently -59.10% below its 200-day simple moving average

50-day SMA

$0.32
CVM price is currently -2.45% below its 50-day simple moving average

RSI

59.07
CVM 14-day relative strength index is 59.07

Volume

3.53
CVM 30-day relative volume is 3.53

ATR

$0.05
CVM average true range is $0.05

10-day Historical Volatility

263.61%
CVM 10-day historical volatility is 263.61%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$62.50
CVM last dividend was $62.50 per share, with an ex-dividend date of August 28, 1996

Next Dividend

-
CVM next dividend has not yet been announced

Dividend per share

Dividend per share

-
CVM annual dividend per share value is unknown

Dividend per share Sector Rank

-
CVM annual dividend per share is unknown

Dividend per share 1-Year Change

-
CVM annual dividend per share 1-year change is unknown

Dividend per share 3-Year Change

-
CVM annual dividend per share 3-year change is unknown

Dividend yield

Dividend yield

-
CVM annual dividend yield value is unknown

Dividend yield Sector Rank

-
CVM annual dividend yield is unknown

Other

Payout ratio

-
CVM annual payout ratio value is unknown

Dividends paid

-
CVM annual dividends paid value is unknown

Free cash flow

-$18.92M
CVM annual free cash flow is -$18.92 million

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
CVM annual revenue value is unknown

Revenue Analysts estimate

-
CVM annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
CVM annual revenue 1-year change is unknown

Revenue Sector rank

-
CVM annual revenue is unknown

EPS

EPS

-$0.51
CVM annual earnings per share is -$0.51

EPS Analysts estimate

-$0.41
CVM annual earnings per share is currently +24.39% higher than the consensus analysts' forecast

EPS 1-year change

+30.14%
CVM annual earnings per share is up +30.14% year-on-year

EPS Sector rank

68.54%
CVM annual earnings per share is higher than 68.54% of companies in Healthcare sector

Profit

Gross profit

-
CVM annual gross profit value is unknown

Gross margin

-
CVM annual gross profit margin value is unknown

Operating profit

-$26.35M
CVM annual operating income is -$26.35 million

Operating margin

-
CVM annual operating profit margin value is unknown

Net income

-$26.92M
CVM annual net profit is -$26.92 million

Net margin

-
CVM annual net profit margin value is unknown

Expenses

Total expenses

$26.35M
CVM annual total expenses is $26.35 million

Operating expenses

$26.35M
CVM annual total operating expenses is $26.35 million

Cost of goods sold

-
CVM annual cost of goods sold value is unknown

Selling, general & administrative expenses

$8.19M
CVM annual SGA is $8.19 million

Depreciation and amortization

$3.97M
CVM annual depreciation & amortization is $3.97 million

Interest expense

$745.70K
CVM annual interest expense is $745.70 thousand

Income tax

-
CVM annual income tax value is unknown

EBIT & EBITDA

EBIT

-$26.17M
CVM annual earnings before interest & taxes is -$26.17 million

EBITDA

-$22.21M
CVM annual EBITDA is -$22.21 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$26.99M
CVM annual total assets is $26.99 million

Non current assets

$20.94M
CVM annual long term assets is $20.94 million

Current assets

$6.06M
CVM annual total current assets is $6.06 million

Cash and cash equivalents

$4.74M
CVM annual cash & cash equivalents is $4.74 million

Accounts receivable

-
CVM annual accounts receivable value is unknown

Inventory

$1.02M
CVM annual inventory is $1.02 million

Liabilities

Total liabilities

$14.12M
CVM annual total liabilities is $14.12 million

Long term liabilities

$9.51M
CVM annual total long term liabilities is $9.51 million

Current liabilities

$4.62M
CVM annual total current liabilities is $4.62 million

Accounts payable

$1.45M
CVM annual accounts payable is $1.45 million

Debt

Total debt

$11.62M
CVM annual total debt is $11.62 million

Total debt 1-year change

-14.37%
CVM annual total debt is down -14.37% year-on-year

Long term debt

$9.38M
CVM annual long term debt is $9.38 million

Short term debt

$2.24M
CVM annual short term debt is $2.24 million

Equity & Capital

Shareholders equity

$12.87M
CVM annual stockholders equity is $12.87 million

Book value

$12.87M
CVM annual book value is $12.87 million

Retained earnings

-$514.01M
CVM annual retained earnings is -$514.01 million

Working capital

$1.44M
CVM annual working capital is $1.44 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$18.81M
CVM annual cash flow from operations is -$18.81 million

Cash from operations 1-year change

+17.67%
CVM annual cash flow from operations is up +17.67% year-on-year

Cash from investing

-$108.10K
CVM annual cash flow from investing activities is -$108.10 thousand

Cash from investing 1-year change

+70.96%
CVM annual cash flow from investing activities is up +70.96% year-on-year

Cash from financing

$19.51M
CVM annual cash flow from financing activities is $19.51 million

Cash from financing 1-year change

+315.64%
CVM annual cash flow from financing activities is up +315.64% year-on-year

CAPEX

CAPEX

-
CVM annual capital expenditures value is unknown

CAPEX 1-year change

-
CVM annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$18.92M
CVM annual free cash flow is -$18.92 million

Free cash flow 1-year change

+18.52%
CVM annual free cash flow is up +18.52% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
CVM annual gross profit margin value is unknown

Operating margin

-
CVM annual operating profit margin value is unknown

Net margin

-
CVM annual net profit margin value is unknown

ROA & ROE

ROA

-99.74%
CVM annual return on assets is -99.74%

ROE

-209.22%
CVM annual return on equity is -209.22%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
CVM price to earnings ratio value is unknown

PE ratio Sector rank

-
CVM price to earnings ratio is unknown

PB Ratio

PB ratio

2.12
CVM price to book ratio is 2.12

PB ratio Sector rank

64.72%
CVM price to book ratio is higher than 64.72% of companies in Healthcare sector

PS Ratio

PS ratio

-
CVM price to sales ratio value is unknown

PS ratio Sector rank

-
CVM price to sales ratio is unknown

Enterprise value

Enterprise value

$30.41M
CVM enterprise value is $30.41 million

Enterprise value Sector rank

36%
CVM enterprise value is higher than 36% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-1.35
CVM EV/EBITDA is -1.35

EV/EBITDA Sector rank

37.79%
CVM EV/EBITDA is higher than 37.79% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.31
CVM annual current ratio is 1.31

Quick ratio

1.09
CVM annual quick ratio is 1.09

Leverage

Debt to equity

0.90
CVM annual debt to equity ratio is 0.90

Interest coverage ratio

-35.10
CVM annual interest coverage ratio is -35.10

Risk & Stability

Piotroski F-Score

-
CVM piotroski f-score value is unknown

Altman Z-Score

-
CVM altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Jul 12, 23 EF Hutton
Buy
Mar 9, 23 EF Hutton
Buy
Dec 29, 22 EF Hutton
Buy
Aug 25, 22 EF Hutton
Buy
Apr 7, 22 EF Hutton
Buy
Jan 13, 20 HC Wainwright & Co.
Buy
Jan 13, 20 H.C. Wainwright
Buy
Feb 20, 13 Taglich Brothers
Speculative Buy
Feb 13, 13 Chardan Capital
Buy
Jan 14, 13 Laidlaw & Co.
Buy

Institutional Ownership

Similar stocks

DOMH logo
Dominari Holdings (DOMH)
LEXX logo
Lexaria Bioscience (LEXX)
VYNE logo
VYNE Therapeutics (VYNE)
DRRX logo
DURECT (DRRX)
NXL logo
Nexalin Technology (NXL)
NRSN logo
NeuroSense Therapeutics (NRSN)
PIII logo
P3 Health Partners (PIII)
ALGS logo
Aligos Therapeutics (ALGS)
POCI logo
Precision Optics (POCI)
  • What is the ticker symbol for CEL-SCI?
  • Does CEL-SCI pay dividends?
  • What sector is CEL-SCI in?
  • What industry is CEL-SCI in?
  • What country is CEL-SCI based in?
  • When did CEL-SCI go public?
  • Is CEL-SCI in the S&P 500?
  • Is CEL-SCI in the NASDAQ 100?
  • Is CEL-SCI in the Dow Jones?
  • When was CEL-SCI's last earnings report?
  • When does CEL-SCI report earnings?
  • Should I buy CEL-SCI stock now?

What is the ticker symbol for CEL-SCI?

The ticker symbol for CEL-SCI is NYSE American:CVM

Does CEL-SCI pay dividends?

No, CEL-SCI does not pay dividends

What sector is CEL-SCI in?

CEL-SCI is in the Healthcare sector

What industry is CEL-SCI in?

CEL-SCI is in the Biotechnology industry

What country is CEL-SCI based in?

CEL-SCI is headquartered in United States

When did CEL-SCI go public?

CEL-SCI's initial public offering (IPO) was on December 8, 1983

Is CEL-SCI in the S&P 500?

No, CEL-SCI is not included in the S&P 500 index

Is CEL-SCI in the NASDAQ 100?

No, CEL-SCI is not included in the NASDAQ 100 index

Is CEL-SCI in the Dow Jones?

No, CEL-SCI is not included in the Dow Jones index

When was CEL-SCI's last earnings report?

CEL-SCI's most recent earnings report was on Feb 13, 2025

When does CEL-SCI report earnings?

The next expected earnings date for CEL-SCI is May 15, 2025

Should I buy CEL-SCI stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page